-
Heat Biologics Cools Off, Bluebird Bio Heats Up
Thursday, December 1, 2016 - 10:54am | 272In a classic example of how trial results can impact stock prices, shares of Heat Biologics Inc (NASDAQ: HTBX) plunged 58 percent in the Thursday’s pre-market hours following a negative outcome of its bladder cancer study, while bluebird bio Inc (NASDAQ: BLUE)’s impressive early cancer...